Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli Institute-Reference-Cited by-同舟云学术

Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli Institute

Published:2001-08 Issue:8 Volume:12 Page:1145-1150
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ferrari S.,Bertoni F.,Mercuri M.,Picci P.,Giacomini S.,Longhi A.,Bacci G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/12/8/1145/19479757/12-8-1145.pdf

Reference30 articles.

1. The treatment of osteosarcoma of the extremities: Twenty year’s experience at the Istituto Ortopedico Rizzoli;Campanacci;Cancer,1981

2. Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery;Rosen;Cancer,1979

3. Control of primary osteosarcoma with chemotherapy;Jaffe;Cancer,1985

4. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity;Link;N Engl J Med,1986

5. Adjuvant chemotherapy for osteosarcoma A randomized prospective trial;Eilber;J Clin Oncol,1987

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral microbiota distinguishes patients with osteosarcoma from healthy controls;Frontiers in Cellular and Infection Microbiology;2024-07-11

2. Impact of Postoperative Radiotherapy on Survival in Primary Osteosarcoma: A population-based study;2024-06-04

3. Cell Cycle Checkpoints p16 and p21—Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma;The Cancer Journal;2024-05

4. Extent of Surgery and Survival of Osteosarcoma: A Retrospective Population-Based Study;Cureus;2024-03-12

5. Systemic Cisplatin Does Not Affect the Bone Regeneration Process in a Critical Size Defect Murine Model;ACS Biomaterials Science & Engineering;2024-02-13